Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
about
Matrix and backstage: cellular substrates for viral vaccinesComparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case studyIdentifying the public health benefits of livestock-dependent, agro-ecosystems under climate change.Systematic review of the economic value of diarrheal vaccinesHealth and economic impact of rotavirus vaccination in GAVI-eligible countriesThe economic burden of pediatric gastroenteritis to Bolivian families: a cross-sectional study of correlates of catastrophic cost and overall cost burden.Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.Reduced price on rotavirus vaccines: enough to facilitate access where most needed?The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infectionsDisease caused by rotavirus infectionCost-effectiveness of rotavirus vaccination in Bolivia from the state perspective.Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countriesThe Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.Global Economic Burden of Norovirus Gastroenteritis.A Qualitative Study of the Status of Children's Play From the Viewpoints of Experts and Suggestions for Promotion Interventions.The Global Economic and Health Burden of Human Hookworm Infection.Exploring household economic impacts of childhood diarrheal illnesses in 3 African settingsThe cost effectiveness of rotavirus vaccination in IranCell tropism predicts long-term nucleotide substitution rates of mammalian RNA viruses.A critical literature review of health economic evaluations of rotavirus vaccination.Rotavirus Vaccine Demand in Pakistan.Respiratory and gastrointestinal epithelial modulation of the immune response during viral infection.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.Economic impact of thermostable vaccines.Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?Economics of vaccines revisited.Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam.The investment case for folic acid fortification in developing countries.Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study.
P2860
Q27025941-EEFF5B1A-0660-4FCA-B58D-B2084FAFA5A1Q28257258-A337184A-0169-4170-8B1B-14A7744594C3Q30686790-A2A5D07B-A2D3-4831-BC32-3A9E304C2F4DQ33577996-8CD06099-0A4D-461D-8C9F-06744A6A8700Q33578406-DAB5D28B-0FF1-461A-B802-29282348D688Q33890633-4F6C68F3-2636-4FF3-95E7-3BEE41CF04DCQ33934529-21BEC57D-B0F7-4D9A-BA66-431510237A7CQ34288836-6F57FB4F-300C-444E-AE1E-EC03B942B52CQ34604662-907A97C0-9346-4D35-B2F3-092B6A01CB34Q34785330-BDB2873E-386B-4D00-B278-86C384BA8EBEQ35166897-F3ACA8B9-4427-4097-A620-0393593A45A1Q35194876-C847BF1E-B96C-48BD-B09B-783F0768E2E9Q35930760-D6C5F3FA-2FF0-420C-A283-926B95FC6007Q35999480-37C8E028-F7A9-415A-9F5F-4A8BCF3645F3Q36074899-20781EA9-A69D-4341-B405-D440F39C91B3Q36126633-8537A247-D89A-4420-B3FC-DAD68446D8DAQ36412068-FCC57A32-DF4E-4975-8AF0-1E54268D0431Q37135008-CBFDB095-668C-49E0-9B20-3CE02431E758Q37458902-C785E822-8147-4F05-853E-DA8BAB9EECEFQ37514764-79C6DDDA-569E-4907-A022-097467306645Q37551348-C9A270CD-7B8B-4023-9F6D-33A1C34DAC39Q37829145-B485C9D5-B271-4EAF-B811-A8C458F17EB1Q37944318-74D957F3-C5B6-4764-8706-F5DE14FBC1E4Q38046665-5CD0B315-6C4B-4B41-9FB7-8BB78ED7AF2CQ39332382-2DE233A2-25CD-49BE-9B9A-1211AFD48576Q40222420-3BA1E8B3-7BCA-4243-BD1A-97D52155D332Q41694316-9509356E-0BAD-4B04-9260-01549BBF4BD7Q41885924-E027F91B-62FA-42E8-9AFC-790BC592AE46Q42250656-69D88CDF-98B6-4FAE-A125-A6C347305598Q44772085-62233AF0-3F1B-4096-92CA-EF6056DB29ACQ47337788-60D13EF9-2429-48E6-9F10-6C63D7EDAD59Q47578662-1C02C06C-1E1A-4AD8-97FD-EFF243497479Q48188462-13826B58-9C48-4E82-BCF8-1D3FECA25202Q49831215-E0F33F57-19C6-492E-AAE4-3C1816186441Q52430899-8DAEE374-7FA1-48CB-BC7C-094D6A26AA4FQ55215664-DA8A40DB-B1BD-4968-A87A-CDD04EB3A87F
P2860
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Economic costs of rotavirus ga ...... ation in developing countries.
@ast
Economic costs of rotavirus ga ...... ation in developing countries.
@en
type
label
Economic costs of rotavirus ga ...... ation in developing countries.
@ast
Economic costs of rotavirus ga ...... ation in developing countries.
@en
prefLabel
Economic costs of rotavirus ga ...... ation in developing countries.
@ast
Economic costs of rotavirus ga ...... ation in developing countries.
@en
P2093
P356
P1476
Economic costs of rotavirus ga ...... ation in developing countries.
@en
P2093
Joseph S Bresee
Laura Jean Podewils
Lynn Antil
Richard D Rheingans
P304
P356
10.1086/605026
P407
P478
200 Suppl 1
P577
2009-11-01T00:00:00Z